Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily LLY Bear 1X Shares

18.00
+0.21611.22%
Volume:668.00
Turnover:12.02K
Market Cap:2.70M
PE:- -
High:18.00
Open:18.00
Low:18.00
Close:17.78
52wk High:31.30
52wk Low:16.40
Shares:150.00K
Float Shares:150.00K
Volume Ratio:0.62
T/O Rate:0.45%
Dividend:1.01
Dividend Rate:5.62%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

'She spent over $1,000 a month on weight-loss drugs': My son wrecked his finances after meeting his girlfriend. Who's to blame?

Dow Jones
·
2 hours ago

Artiva Biotherapeutics Names Elaine Sorg to Board of Directors

Reuters
·
2 hours ago

Berenberg Adjusts Price Target on Eli Lilly to $1,050 From $950, Maintains Hold Rating

MT Newswires Live
·
4 hours ago

Three multinationals pay almost half of all Irish corporate tax, watchdog says

Reuters
·
5 hours ago

U.S. RESEARCH ROUNDUP-EBay, Huntsman, Palo Alto

Reuters
·
6 hours ago

Eli Lilly : Berenberg Raises Target Price to $1050 From $950

THOMSON REUTERS
·
8 hours ago

Eli Lilly Stock (LLY) in Focus as Zepbound Found to Help Treat Psoriasis

TIPRANKS
·
Yesterday

Lurpak-maker Arla sees lower dairy prices and boost from protein products

Reuters
·
Yesterday

BRIEF-Lilly's Taltz (Ixekizumab) And Zepbound (Tirzepatide) Used Together Delivered Superior Efficacy In First-Of-Its-Kind Phase 3B Trial

Reuters
·
Yesterday

Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study

Reuters
·
Yesterday

Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Used Together Delivered Superior Efficacy in First-of-Its-Kind Phase 3B Trial for Adults With Psoriasis and Obesity or Overweight

THOMSON REUTERS
·
Yesterday

Eli Lilly: Taltz, Zepbound Met Primary Endpoint of Superiority VS. Taltz Monotherapy in Achieving Complete Skin Clearance, ≥10% Weight Loss

THOMSON REUTERS
·
Yesterday

Eli Lilly: at 36 Weeks, Treatment With Taltz, Zepbound Met Primary and All Key Secondary Endpoints

THOMSON REUTERS
·
Yesterday

Eli Lilly: in Secondary Endpoint, Patients Taking Taltz, Zepbound Were 40% More Likely to Achieve Pasi 100 Compared to Those Taking Taltz Alone

THOMSON REUTERS
·
Yesterday

'His credit rating is wrecked': My son and his girlfriend mingled their finances. Big mistake.

Dow Jones
·
Yesterday

Daiwa Securities Adjusts Price Target on Eli Lilly to $1,250 From $1,230, Maintains Buy Rating

MT Newswires Live
·
Yesterday

BUZZ-Australia's CSL recovers after signing licensing deal with Eli Lilly

Reuters
·
Yesterday

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Yesterday

BRIEF-CSL And Lilly Enter Licensing Agreement For Clazakizumab

Reuters
·
Yesterday

Eli Lilly Stock (LLY) Rises on Plan to Invest $1 Billion in India

TIPRANKS
·
Yesterday